Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 10
Submit an article Journal homepage
551
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Prolonged immunochemotherapy with rituximab, cytarabine and fludarabine added to cyclophosphamide, doxorubicin, vincristine and prednisolone and followed by rituximab maintenance in untreated elderly patients with mantle cell lymphoma: a prospective study by the Finnish Lymphoma Group

Riikka RätyDepartment of Hematology, Helsinki University Central Hospital, Helsinki, FinlandCorrespondence[email protected]
,
Tuomo HonkanenDepartment of Medicine, Päijänne Tavastia Central Hospital, Lahti, Finland
,
Esa JantunenUniversity of Eastern Finland and Department of Medicine, Kuopio University Hospital, Kuopio, Finland
,
Sirkku JyrkkiöDepartment of Oncology and Radiotherapy, Turku University Central Hospital, Turku, Finland
,
Marja-Liisa Karjalainen-LindsbergHuslab, Pathology Department
,
Outi KuittinenDepartment of Oncology, Oulu University Hospital, Oulu, Finland
,
Minna LehtoDepartment of Medicine, Päijänne Tavastia Central Hospital, Lahti, Finland
,
Maija MikkolaDepartment of Medicine, Mikkeli Central Hospital, Mikkeli, Finland
,
Eira PoikonenDepartment of Hematology, Helsinki University Central Hospital, Helsinki, Finland
,
Auvo RauhalaDepartment of Medicine, Vaasa Central Hospital, Vaasa, Finland
,
Johanna RimpiläinenDepartment of Medicine, North Karelia Central Hospital, Joensuu, Finland
,
Anu RäsänenDepartment of Medicine, Kymenlaakso Central Hospital, Kotka, Finland
,
Sanna SiitonenHuslab, Laboratory Department, Helsinki University Central Hospital, Helsinki, Finland
,
Merja SuominenDepartment of Medicine, Kanta-Häme Central Hospital, Hämeenlinna, Finland
,
Mirja VapaataloDepartment of Hematology, Helsinki University Central Hospital, Helsinki, Finland
&
Erkki ElonenDepartment of Hematology, Helsinki University Central Hospital, Helsinki, Finland
 show all
Pages 1920-1928 | Received 08 Sep 2011, Accepted 27 Feb 2012, Published online: 23 Apr 2012

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Chadi Nabhan, Nicholas J. Ollberding, Dana Villines, Brian C.-H. Chiu, Donne Bennett D. Caces, Tina V. Valdez, Michele Ghielmini, Shu-Fang Hsu Schmitz & Sonali M. Smith. (2014) A systematic review of comparative schedule-related toxicities with maintenance rituximab in follicular and mantle cell lymphomas. Leukemia & Lymphoma 55:6, pages 1288-1294.
Read now
Simon Husby, Christian Geisler & Kirsten Grønbæk. (2013) MicroRNAs in mantle cell lymphoma. Leukemia & Lymphoma 54:9, pages 1867-1875.
Read now

Articles from other publishers (12)

Minna Harmanen, Tuula Klaavuniemi, Marc Sorigue, Madiha Khan, Roosa Prusila, Esa Kari, Erika Alanne, Aino Rajamäki, Kaisa Sunela, Arja Jukkola, Esa Jantunen, Juan-Manuel Sancho, Sanna Ketola, Hanne Kuitunen, Tuomas Selander, Aino Rönkä & Outi Kuittinen. (2023) Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results Among Patients With Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion Criteria. HemaSphere 7:10, pages e954.
Crossref
Minna Harmanen, Mika Hujo, Reijo Sund, Marc Sorigue, Madiha Khan, Roosa Prusila, Tuula Klaavuniemi, Esa Kari, Esa Jantunen, Kaisa Sunela, Aino Rajamäki, Erika Alanne, Hanne Kuitunen, Juan‐Manuel Sancho, Arja Jukkola, Aino Rönkä & Outi Kuittinen. (2022) Survival of patients with mantle cell lymphoma in the rituximab era: Retrospective binational analysis between 2000 and 2020. British Journal of Haematology 201:1, pages 64-74.
Crossref
Sumita Ratnasingam, Joshua Casan, Jake Shortt, Eliza Hawkes, Michael Gilbertson, Zoe McQuilten, George Grigoriadis, Kay Thwe Htun, Swe Myo Htet, Philip Campbell, Khai Li Chai, Hang Quach, Sushrut Patil & Stephen Opat. (2019) Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphoma. Scientific Reports 9:1.
Crossref
Sabrina Wildner, Sara Huber, Christof Regl, Christian G. Huber, Urs Lohrig & Gabriele Gadermaier. (2019) Aptamers as quality control tool for production, storage and biosimilarity of the anti-CD20 biopharmaceutical rituximab. Scientific Reports 9:1.
Crossref
Haige Ye, Aakash Desai, Dongfeng Zeng, Jorge Romaguera & Michael L. Wang. (2018) Frontline Treatment for Older Patients with Mantle Cell Lymphoma. The Oncologist 23:11, pages 1337-1348.
Crossref
Arati A. Inamdar, Andre Goy, Nehad M. Ayoub, Christen Attia, Lucia Oton, Varun Taruvai, Mark Costales, Yu-Ting Lin, Andrew Pecora & K. Stephen Suh. (2016) Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents. Oncotarget 7:30, pages 48692-48731.
Crossref
Narges Seyfizadeh, Nayer Seyfizadeh, Justin Hasenkamp & Sara Huerta-Yepez. (2016) A molecular perspective on rituximab: A monoclonal antibody for B cell non Hodgkin lymphoma and other affections. Critical Reviews in Oncology/Hematology 97, pages 275-290.
Crossref
Irit Avivi & Andre Goy. (2015) Refining the Mantle Cell Lymphoma Paradigm: Impact of Novel Therapies on Current Practice. Clinical Cancer Research 21:17, pages 3853-3861.
Crossref
Simon Husby, Ulrik RalfkiaerChristian GardeRoza Zandi, Sara EkArne KolstadMats JerkemanAnna LaurellRiikka RätyLone B. Pedersen, Anja Pedersen, Mats EhingerChrister SundströmMarja-Liisa Karjalainen-Lindsberg, Jan Delabie, Erik Clasen-LindePeter Brown, Jack B. Cowland, Christopher T. WorkmanChristian H. Geisler & Kirsten Grønbæk. (2015) miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator. Blood 125:17, pages 2669-2677.
Crossref
Leonardo J. Enciso, Martha L. Suarez & Marcos Arango. (2015) Resultados del tratamiento del linfoma de células del manto con varios regímenes de inmunoquimioterapia: estudio retrospectivo. Revista Colombiana de Cancerología 19:2, pages 71-80.
Crossref
Elias Campo & Simon Rule. (2015) Mantle cell lymphoma: evolving management strategies. Blood 125:1, pages 48-55.
Crossref
Eva HosterWolfram KlapperOlivier HermineHanneke C. Kluin-NelemansJan WalewskiAchiel van HoofMarek TrnenyChristian H. GeislerFrancesco Di RaimondoMichal SzymczykStephan StilgenbauerCatherine ThieblemontMichael HallekRoswitha ForstpointnerChristiane PottVincent RibragJeanette DoorduijnWolfgang HiddemannMartin H. DreylingMichael Unterhalt. (2014) Confirmation of the Mantle-Cell Lymphoma International Prognostic Index in Randomized Trials of the European Mantle-Cell Lymphoma Network. Journal of Clinical Oncology 32:13, pages 1338-1346.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.